Fundraising FoxCureAge
1 known investors
Find your way into CureAge
Sign up to see every warm intro you have to CureAge
- Paths you didn't know you had: your email and LinkedIn already hold routes to the CureAge team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CureAge Therapeutics develops a cell delivery platform targeting Schwann cells for treating neurofibromatosis type 1 (NF1) peripheral tumors. The company emerged from a partnership between the Children's Tumor Foundation and Deep Science Ventures to address unmet needs in the neurofibromatosis patient community.
Founders & leadership
Board
K
KerstinDirector, Pharma at Deep Science Ventures
Investors · 1
Frequently asked questions
- What does CureAge do?
- CureAge Therapeutics develops a cell delivery platform targeting Schwann cells for treating neurofibromatosis type 1 (NF1) peripheral tumors. The company emerged from a partnership between the Children's Tumor Foundation and Deep Science Ventures to address unmet needs in the neurofibromatosis patient community.
- Who are CureAge's investors?
- CureAge's investors include Deep Science Ventures.